Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma.

ABSTRACT:

Backgrounds/aims

This study aimed to compare the outcomes of liver resection (LR) and transarterial chemoembolization (TACE) in patients with multinodular hepatocellular carcinoma (HCC) within the Milan criteria who were not eligible for liver transplantation.

Methods

We retrospectively analyzed 483 patients with multinodular HCC within the Milan criteria, who underwent either LR or TACE as an initial therapy between 2013 and 2022. The overall survival (OS) in the entire population and recurrence-free survival (RFS) in patients who underwent LR and TACE and achieved a complete response were analyzed. Propensity score (PS) matching analysis was also used for a fair comparison of outcomes between the two groups.

Results

Among the 483 patients, 107 (22.2%) and 376 (77.8%

SUBMITTER: Yang J 

PROVIDER: S-EPMC11449568 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature